Summary
Serum lipid and lipoprotein levels were evaluated in 50 insulin-treated diabetic outpatients (25 male and 25 female) and in 46 normal volunteers (22 male and 24 female). In these groups metabolic evaluation was carried out by assaying fasting plasma glucose, glucose in urine and glycosylated hemoglobin (G-HbA1). No differences were observed in the lipid and lipoprotein patterns between diabetic patients and normals. HDL values were significantly lower in male subjects, diabetic and normal, as compared to females, but there were no differences between the diabetic and the normal group. G-HbA1 was significantly correlated to fasting plasma glucose and glucose in urine, but also to WS-TG and VLDL-TG. Fasting plasma glucose too was correlated to WS-TG and VLDL-TG. Moreover, a negative correlation was found between HDL-Ch and WS-TG and VLDL-TG. These results show that sufficiently well-controlled insulin-treated diabetics do not have altered plasma lipid and lipoprotein levels. In particular, in these patients HDL-Ch values can be normal, because insulin levels are sufficient to activate lipoprotein lipase and to guarantee an adequate plasma VLDL clearance.
Similar content being viewed by others
References
Aleyassine H., Gardiner R. J., Tonks D. B., Koch P.: Glycosylated hemoglobin in diabetes mellitus: correlations with fasting plasma glucose, serum lipids and glycosuria — Diabetes Care3, 508, 1980.
Ballantyne D., White C., Strevens E. A., Lawrie T. D. V., Lorimer A. R., Manderson W. G., Morgan H. G.: Lipoprotein concentrations in untreated adult onset diabetes mellitus and the relationship of the fasting plasma triglyceride concentrations to insulin secretion — Clin. chim. Acta78, 323, 1977.
Balodimos M. C.: Diabetic nephropathy. In:Marble A., White P., Bradley R. F., Krall L. P. (Eds): Joslin’s Diabetes mellitus — 11th ed. Lea and Febiger, Philadelphia, 1971; p. 526.
Barr D. P., Russ E. M., Eder H. A.: Protein-lipid relationships in human plasma in atherosclerosis and related conditions — Amer. J. Med.11, 480, 1951.
Beach K. W., Brunzell J. D., Conquest L. L., Strandness D. E.: The correlation of arteriosclerosis obliterans with lipoproteins in insulin-dependent and non-insulin-dependent diabetes — Diabetes28, 836, 1979.
Bercquist N.: Serum lipids in ambulatory diabetic clientele — Acta med. scand.187, 213, 1970.
Calvert G. D., Graham J. J., Mannik T., Wise P. H., Yeates R. A.: Effects of therapy on plasma-high-density-lipoprotein-cholesterol concentration in diabetes mellitus — Lancetii, 66, 1978.
Daubresse J. C., Lemy C., Bailly A., Meunier J. C.: The usefulness of a rapid method for total fast hemoglobins determination in screening for diabetes control — Diabète Métab.5, 301, 1979.
Ditzel J., Nielsen N. V., Kjaergaard J.-J.: Hemoglobin Ak and red cell oxygen release capacity in relation to early retinal changes in newly discovered overt and chemical diabetics — Metabolism28 (Suppl. 1), 440, 1979.
Dix D., Cohen P., Kingsley S., Lea M. J., Senkbell J., Sexton K.: Interference by lactescence in glycohemoglobin analysis — Clin. Chem.25, 494, 1979.
Dunn P. J., Cole R. A., Soeldner J. S., Gleason R. E., Kwa E., Firoozabadi H., Younger D., Graham C. A.: Temporal relationship of glycosylated hemoglobin concentrations to glucose control in diabetics — Diabetologia17, 213, 1979.
Eckel R. H., Albers J. J., Cheung M. G., Wahl P. W., Lindgren F. T., Bierman E. L.: High density lipoprotein composition in insulin dependent diabetes mellitus — Diabetes30, 132, 1981.
Elkeles R. S., Wu J., Hambley J.: Haemoglobin A1, blood glucose, and high-density lipoprotein cholesterol in insulin-requiring diabetes — Lancetii, 547, 1978.
Fedele D., Fellin R., Lapolla A., Baggio G., Baiocchi M. R., Frigato F., Tiengo A.: Lipidi plasmatici e controllo metabolico della malattia diabetica. In:Erle G. (Ed.): Atti del Convegno: Emoglobina glicosilata e diabete mellito. La Grafica e Stampa, 1980; p. 121.
Fedele D., Lapolla A., Baldo G., Marescotti C., Tiengo A.: Glycosylated hemoglobin (G-Hb) in the endogenous hypertriglyceridemia — (Submitted for publication).
Ganda O. P.: Pathogenesis of macrovascular disease in the human diabetic — Diabetes29, 931, 1980.
Hankins W. D., Holladay L.: A temperature conversion nomogram for glycosylated hemoglobin analysis — Clin. chim. Acta104, 251, 1980.
Hayes T. M.: Plasma lipoproteins in adult diabetes — Clin. Endocr.1, 247, 1972.
Howard B. V., Savage P. J., Bennion L. J., Bennett P. H.: Lipoprotein composition in diabetes mellitus — Atherosclerosis30, 153, 1978.
Huggett A. S. F., Nixon D. A.: Use of glucose-oxidase, peroxidase and o-dianisine in the determination of blood and urine glucose — Lancetii, 368, 1957.
Kaufmann R. L., Assal J. Ph., Soeldner J. S., Wilmshurst E. G., Lemaire J. R., Gleason R. E., White P.: Plasma lipid levels in diabetic children. Effect of diet restricted in cholesterol and saturated fats — Diabetes24, 672, 1975.
Langberg R.: Diabetes mellitus mortality in the United States, 1950–1967 — Public Health Service Publication No. 1000, Series 20, No. 10. Washington, D.C., 1971.
Lipid Research Clinics Program: Manual of Laboratory Operations. Lipid and lipoprotein analysis.Gpodehw Publ. No. (NIH) 75-628, Washington, D.C., 1974; vol. 1, p. 56.
Lopes-Virella M. F. L., Stone P. G., Colwell J. A. Jr.: Serum high density lipoprotein in diabetic patients — Diabetologia13, 285, 1977.
Mattock M. B., Fuller J. H., Maude P. S., Keen H.: Lipoproteins and plasma cholesterol esterification in normal and diabetic subjects — Atherosclerosis34, 437, 1979.
Metropolitan Life Insurance Company: New weight standards for men and women — Stat. Bull. Metropol. Life Insur. Co.40, 1, 1959.
Nikkilä E.: Studies on the lipid-protein relationships in normal and pathologic sera and the effect of heparin on serum lipoproteins — Scand. J. clin. Lab. Invest. 5 (Suppl. 8) 158, 1953.
Nikkilä E. A., Hormila P.: Serum lipids and lipoproteins in insulin-treated adult diabetes. Demonstration of increased high density lipoprotein concentrations — Diabetes27, 1078, 1978.
Nikkilä E. A., Kekki M.: Plasma triglyceride transport kinetics in diabetes mellitus — Metabolism22, 1, 1973.
Peterson C. M., Koenic R. J., Jones R. L., Saudek C. D., Cerami A.: Correlation of serum triglyceride levels and hemoglobin Ah concentrations in diabetes mellitus — Diabetes26, 507, 1977.
Pietri A., Dunn F. L., Raskin P.: The effect of improved diabetic control on plasma lipid and lipoprotein levels. A comparison of conventional therapy in continuous subcutaneous insulin infusion — Diabetes29, 1001, 1980.
Röschlau P., Bernt E., Gruber W.: Enzymatische Bestimmung des Gesamt-Cholesterins im Serum — Z. klin. Chem. klin. Biochem.12, 226, 1974.
Saudek C. D., Eder H. A.: Lipid metabolism in diabetes mellitus — Amer. J. Med.66, 843, 1979.
Schaefer E. J., Levy R. I., Anderson D. W., Danner R. N., Brewer H. B. Jr., Blackwelder W. C.: Plasma triglycerides in regulation of HDL-cholesterol levels — Lancetii, 391, 1978.
Schonfeld G., Birge C., Miller J. Ph., Kessler G., Santiago J.: Apolipoprotein B levels and altered lipoprotein composition in diabetes — Diabetes23, 827, 1974.
Seidel D. H., Wieland H., Ruppert C.: Improved techniques for assessment of plasma lipoprotein patterns. I. Precipitation in gel after electrophoresis with polyanionic compounds — Clin. Chem.19, 737, 1973.
Shafrir E.: Hyperlipidemia in diabetes. In:Sussman K. E., Metz R. J. S. (Eds): Diabetes mellitus diagnosis and treatment. 4th ed. American Diabetes Association, New York. 1975; p. 221.
Sommariva D., Scotti L., Massaroli C., Zanaboni L., Bonfiglioli D., Negrati M., Micossi P., Raggi U., Fasoli A.: Serum lipoproteins in diabetes: relation of alphalipoprotein level to therapy — Acta diabet. lat.17, 237, 1980.
Sosenko J. M., Breslow J. L., Miettinen O. S., Gabbay K. H.: Hyperglycemia and plasma lipid levels. A prospective study of young insulin-dependent diabetic patients — New Engl. J. Med.302, 650, 1980.
Tamborlane W. V., Sherwin R. S., Genel M., Felig P.: Restoration of normal lipid and amino acid metabolism in diabetic patients treated with a portable insulin infusion pump — Lanceti, 1258, 1979.
Taskinen M.-R., Nikkilä E. A.: Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes. Relation to high-density and very-low density lipoproteins and response to treatment — Diabetologia17, 351, 1979.
Wahlefeld A. W.: Triglyceride determination after enzymatic hydrolysis. In:Bergmeier H. U. (Ed.): Methoden der enzymatischen Analyse. III. Aufl. Verlag Chemie, Weinheim, 1974; vol. 2, p. 1878.
West K. M.: Epidemiology of diabetes and its vascular lesions. Elsevier, New York, 1978.
Wilson D. E., Schreibman P. H., Day V. C., Arky R. A.: Hyperlipidemia in an adult diabetic population — J. chron. Dis.23, 501, 1970.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fedele, D., Baggio, G., Fellin, R. et al. Serum lipid and lipoprotein levels and metabolic control in insulin-treated diabetics. Acta diabet. lat 19, 151–159 (1982). https://doi.org/10.1007/BF02581151
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02581151